AML (Acute Myeloid Leukemia),Leukemia ADMIRAL trial: Gilteritinib vs. Chemotherapy for FLT3-Mutated AML Transplant Outcomes Mar 23, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Ibrutinib Improves OS in CLL Patients ≥65 Years as First-Line Treatment Mar 10, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia 4-Year Follow-Up Data of Ibrutinib and Venetoclax Combo in CLL Patients Mar 10, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Comparing Venetoclax and Chemoimmunotherapy for CLL: GAIA/CLL13 Phase 3 Trial Mar 10, 2023
